Nomura Asset Management International’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Nomura Asset Management International’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22K	Hold	400,000	–	–	﹤0.01%	1332
2026 Q1	$99K	Hold	400,000	–	–	﹤0.01%	1229
2025 Q4	$168K	Buy	+400,000	New	+$212K	﹤0.01%	1229

Other funds holding SGMO

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

AIM

Axiom Investment Management New York $150M AUM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Nomura Asset Management International's SGMO Position: Q2 2026 in Review

Nomura Asset Management International held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q2 2026 at 400,000 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1332.

Nomura Asset Management International first reported a position in SGMO in Q4 2025 and has held it in 3 quarters since. The position peaked at $168K in Q4 2025. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Nomura Asset Management International held 400,000 shares of SANGAMO THERAPEUTICS INC worth $22K as of Q2 2026.
Nomura Asset Management International left its SANGAMO THERAPEUTICS INC share count unchanged in Q2 2026.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1332 holding.
Nomura Asset Management International first reported a position in SANGAMO THERAPEUTICS INC in Q4 2025 and has held it in 3 quarters since.
Nomura Asset Management International's SANGAMO THERAPEUTICS INC position peaked at $168K in Q4 2025.
6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.